EXANE DERIVATIVES - CHECKPOINT THERAPEUTICS INC ownership

CHECKPOINT THERAPEUTICS INC's ticker is CKPT and the CUSIP is 162828107. A total of 69 filers reported holding CHECKPOINT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of CHECKPOINT THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,659,000
-96.8%
1,611
-94.4%
0.00%
-92.9%
Q1 2022$51,067,000
-47.5%
28,853
-7.7%
0.01%
-41.7%
Q4 2021$97,221,000
-38.9%
31,262
-35.2%
0.02%
-36.8%
Q3 2021$159,153,00048,2300.04%
Other shareholders
CHECKPOINT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
CVI Holdings, LLC 2,622,546$7,028,0002.86%
SABBY MANAGEMENT, LLC 931,240$2,496,0000.37%
IRONWOOD INVESTMENT MANAGEMENT LLC 136,045$365,0000.26%
Frontier Wealth Management LLC 353,980$949,0000.09%
Spotlight Asset Group, Inc. 80,000$214,0000.08%
Virtu Financial LLC 30,345$81,0000.01%
PARK AVENUE SECURITIES LLC 53,825$144,0000.01%
CHIRON CAPITAL MANAGEMENT, LLC 2,000$5,0000.00%
B. Riley Wealth Advisors, Inc. 29,500$80,0000.00%
FENIMORE ASSET MANAGEMENT INC 32,400$87,0000.00%
View complete list of CHECKPOINT THERAPEUTICS INC shareholders